Applying Science to the Improved Diagnosis and Treatment of Patients with Alzheimer’s Disease
Jointly provided by Postgraduate Institute for Medicine and Catamount Medical Education.
Supported by an independent educational grant from Forest Laboratories Inc.
Scroll to the Bottom of this Information to Begin this Course
Release date: April 1, 2016
Valid through: April 1, 2017
Topic: Alzheimer’s Disease
Estimated Time to Complete Activity: 45 minutes
Target Audience (Learners)
Neurologists, geriatricians, psychiatrists, and others who treat patients with Alzheimer’s Disease (AD).
Upon completion of this activity, participants will be able to:
- Describe the most current understanding of the pathophysiology of AD, including risk factors
- Utilize current criteria for the diagnosis of mild cognitive impairment (MCI) and AD
- Discuss the differential diagnosis of MCI and dementia based on individual patients
- List the common biomarkers for diagnosing AD
- Review criteria for the staging of AD dementia
- Discuss current and emerging treatment options for AD
- Physicians — maximum of 0.75 AMA PRA Category 1 Credits™
All other healthcare professionals completing this course will be issued a statement of participation.
Bradford Dickerson, MD
Associate Professor of Neurology, Harvard Medical School
Director, Frontotemporal Disorders Unit, Massachusetts General Hospital
Co-Investigator, Alzheimer’s Disease Research Center, Massachusetts General Hospital
Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Catamount Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures of Conflicts of Interest
- Royalty: Oxford University Press
- Consulting Fees: Forum Pharmaceuticals, Ionis Pharmaceuticals, Haymarket Media, Med Learning Group
- Data Safety Monitoring Board: Merck
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
The following PIM planners and managers, Trace Hutchison, PharmD, Judi Smelker-Mitchek, RN, BSN, Samantha Mattiucci, PharmD, CHCP, and Jan Schultz, MSN, RN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
The following Catamount Medical Education planners and managers, Adrienne Drinkwater, PhD, Jennifer Green, and William Hofferth, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Hardware and Software Requirements
This site is best viewed with an HTML5 compatible browser, this list includes the current versions of Microsoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player. Where such software is required it will be indicated.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.